162 related articles for article (PubMed ID: 38203331)
1. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts.
Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203331
[TBL] [Abstract][Full Text] [Related]
2. A cancer-specific anti-podocalyxin monoclonal antibody (60-mG
Kaneko MK; Ohishi T; Kawada M; Kato Y
Biochem Biophys Rep; 2020 Dec; 24():100826. PubMed ID: 33088928
[TBL] [Abstract][Full Text] [Related]
3. Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.
Itai S; Ohishi T; Kaneko MK; Yamada S; Abe S; Nakamura T; Yanaka M; Chang YW; Ohba SI; Nishioka Y; Kawada M; Harada H; Kato Y
Oncotarget; 2018 Apr; 9(32):22480-22497. PubMed ID: 29854293
[TBL] [Abstract][Full Text] [Related]
4. Epitope Mapping of a Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (PcMab-60) Using Enzyme-Linked Immunosorbent Assay and Surface Plasmon Resonance.
Asano T; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):227-232. PubMed ID: 34678093
[TBL] [Abstract][Full Text] [Related]
5. 47-mG
Kaneko MK; Itai S; Yamada S; Kato Y
Monoclon Antib Immunodiagn Immunother; 2018 Jun; 37(3):158-161. PubMed ID: 29630446
[TBL] [Abstract][Full Text] [Related]
6. PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.
Ogasawara S; Kaneko MK; Yamada S; Honma R; Nakamura T; Saidoh N; Yanaka M; Yoshida K; Fujii Y; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Apr; 36(2):50-56. PubMed ID: 28384052
[TBL] [Abstract][Full Text] [Related]
7. Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.
Kaneko MK; Kunita A; Yamada S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Ogasawara S; Ohishi T; Abe S; Itai S; Harada H; Kawada M; Nishioka Y; Fukayama M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):157-162. PubMed ID: 28665782
[TBL] [Abstract][Full Text] [Related]
8. Anti-Podocalyxin Monoclonal Antibody 47-mG
Yamada S; Itai S; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):91-94. PubMed ID: 29649375
[TBL] [Abstract][Full Text] [Related]
9. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody (134-mG
Nanamiya R; Takei J; Ohishi T; Asano T; Tanaka T; Sano M; Nakamura T; Yanaka M; Handa S; Tateyama N; Harigae Y; Saito M; Suzuki H; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Feb; 41(1):1-7. PubMed ID: 35225663
[TBL] [Abstract][Full Text] [Related]
10. A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG
Kawabata H; Ohishi T; Suzuki H; Asano T; Kawada M; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):320-327. PubMed ID: 35483055
[TBL] [Abstract][Full Text] [Related]
11. Determination of critical epitope of PcMab-47 against human podocalyxin.
Itai S; Yamada S; Kaneko MK; Kato Y
Biochem Biophys Rep; 2018 Jul; 14():78-82. PubMed ID: 29872738
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H
Tanaka T; Suzuki H; Ohishi T; Kaneko MK; Kato Y
Cancer Sci; 2024 Jan; 115(1):298-309. PubMed ID: 37942574
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas.
Itai S; Yamada S; Kaneko MK; Harada H; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Oct; 36(5):220-223. PubMed ID: 28873000
[TBL] [Abstract][Full Text] [Related]
14. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG
Tateyama N; Nanamiya R; Ohishi T; Takei J; Nakamura T; Yanaka M; Hosono H; Saito M; Asano T; Tanaka T; Sano M; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):177-183. PubMed ID: 34424762
[TBL] [Abstract][Full Text] [Related]
15. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Exerted Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor.
Tanaka T; Ohishi T; Saito M; Suzuki H; Kaneko MK; Kawada M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):142-149. PubMed ID: 35666554
[TBL] [Abstract][Full Text] [Related]
16. A defucosylated anti-PD-L1 monoclonal antibody 13-mG
Takei J; Ohishi T; Kaneko MK; Harada H; Kawada M; Kato Y
Biochem Biophys Rep; 2020 Dec; 24():100801. PubMed ID: 32923698
[TBL] [Abstract][Full Text] [Related]
17. A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG
Asano T; Tanaka T; Suzuki H; Li G; Ohishi T; Kawada M; Yoshikawa T; Kaneko MK; Kato Y
Antibodies (Basel); 2022 Nov; 11(4):. PubMed ID: 36546899
[TBL] [Abstract][Full Text] [Related]
18. Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2.
Itai S; Yamada S; Kaneko MK; Sano M; Nakamura T; Yanaka M; Handa S; Hisamatsu K; Nakamura Y; Furusawa Y; Fukui M; Ohishi T; Kawada M; Harada H; Kato Y
Biochem Biophys Rep; 2018 Sep; 15():93-96. PubMed ID: 30105309
[TBL] [Abstract][Full Text] [Related]
19. A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG
Kawabata H; Suzuki H; Ohishi T; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):59-66. PubMed ID: 35471051
[TBL] [Abstract][Full Text] [Related]
20. Defucosylated Monoclonal Antibody (H
Suzuki H; Ohishi T; Nanamiya R; Kawada M; Kaneko MK; Kato Y
Curr Issues Mol Biol; 2023 Sep; 45(10):7734-7748. PubMed ID: 37886932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
